DK0725655T4 - Anvendelse af forbindelser, der er i stand til at binde til glycoproteinet gpllb/llla, til forebyggelse af restenose - Google Patents

Anvendelse af forbindelser, der er i stand til at binde til glycoproteinet gpllb/llla, til forebyggelse af restenose

Info

Publication number
DK0725655T4
DK0725655T4 DK95902460T DK95902460T DK0725655T4 DK 0725655 T4 DK0725655 T4 DK 0725655T4 DK 95902460 T DK95902460 T DK 95902460T DK 95902460 T DK95902460 T DK 95902460T DK 0725655 T4 DK0725655 T4 DK 0725655T4
Authority
DK
Denmark
Prior art keywords
restenosis
immunoglobulins
iiia
glycoprotein
binding
Prior art date
Application number
DK95902460T
Other languages
Danish (da)
English (en)
Other versions
DK0725655T3 (da
Inventor
Harlan F Weisman
Barry S Coller
Original Assignee
Univ New York State Res Found
Centocor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22523494&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0725655(T4) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Univ New York State Res Found, Centocor Inc filed Critical Univ New York State Res Found
Application granted granted Critical
Publication of DK0725655T3 publication Critical patent/DK0725655T3/da
Publication of DK0725655T4 publication Critical patent/DK0725655T4/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2839—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2839—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily
    • C07K16/2848—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily against integrin beta3-subunit-containing molecules, e.g. CD41, CD51, CD61
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Prostheses (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK95902460T 1993-11-05 1994-11-07 Anvendelse af forbindelser, der er i stand til at binde til glycoproteinet gpllb/llla, til forebyggelse af restenose DK0725655T4 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14792893A 1993-11-05 1993-11-05
PCT/US1994/012779 WO1995012412A1 (en) 1993-11-05 1994-11-07 Platelet-specific chimeric immunoglobulin and methods of use therefor

Publications (2)

Publication Number Publication Date
DK0725655T3 DK0725655T3 (da) 2004-01-05
DK0725655T4 true DK0725655T4 (da) 2009-05-18

Family

ID=22523494

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95902460T DK0725655T4 (da) 1993-11-05 1994-11-07 Anvendelse af forbindelser, der er i stand til at binde til glycoproteinet gpllb/llla, til forebyggelse af restenose

Country Status (15)

Country Link
EP (2) EP0725655B2 (de)
JP (1) JPH09504795A (de)
CN (2) CN1140295C (de)
AT (1) ATE247980T1 (de)
AU (2) AU1172495A (de)
CA (1) CA2175214A1 (de)
DE (1) DE69433091T3 (de)
DK (1) DK0725655T4 (de)
ES (1) ES2204937T5 (de)
HK (1) HK1054682B (de)
NZ (2) NZ502819A (de)
PT (1) PT725655E (de)
RU (1) RU2158135C2 (de)
UA (1) UA37249C2 (de)
WO (1) WO1995012412A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5770198A (en) * 1988-05-18 1998-06-23 The Research Foundation Of The State Of New York Platelet-specific chimeric 7E3 immunoglobulin
US5753230A (en) 1994-03-18 1998-05-19 The Scripps Research Institute Methods and compositions useful for inhibition of angiogenesis
WO1996040250A2 (en) * 1995-06-07 1996-12-19 Centocor, Inc. Platelet-specific chimeric immunoglobulin and methods of use therefor
CA2282501A1 (en) * 1997-02-19 1998-08-27 Centocor, Inc. Sustained drug delivery and compositions useful therefor
US6228360B1 (en) * 1998-08-19 2001-05-08 Ajinomoto Co., Inc. Antithrombotic agent and humanized anti-von Willebrand factor monoclonal antibody
RU2200481C2 (ru) * 2001-02-22 2003-03-20 Научно-Исследовательский Институт Трансплантологии И Искусственных Органов Способ лечения острой сердечной недостаточности
FR2843396B1 (fr) * 2002-08-07 2005-04-15 Bio Rad Pasteur Anticorps specifiques pour le diagnostic de l'insuffisance cardiaque
RU2240136C1 (ru) * 2003-04-10 2004-11-20 Государственное учреждение "Московский научно-исследовательский институт эпидемиологии и микробиологии им. Г.Н.Габричевского МЗ РФ" Композиция, содержащая иммуноглобулины и целевые добавки

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1297815C (en) * 1985-06-07 1992-03-24 Barry S. Coller Fibrinogen blocking monoclonal antibody
CA1297816C (en) * 1985-06-14 1992-03-24 Barry S. Coller Platelet function inhibiting monoclonal antibody fragment
KR940009084B1 (ko) * 1988-05-18 1994-09-29 체크 포인트 시스템스, 인코오퍼레이티드 자기 및 공명회로 검출용 안테나 시스템
DE69020548T2 (de) * 1989-04-03 1996-03-07 Centocor Inc Blutplättchenspezifische immunokonjugate.
WO1993006863A1 (en) * 1991-09-30 1993-04-15 Biogen, Inc. Inhibition of vascular narrowing using anti-padgem antibodies
JP2723671B2 (ja) * 1991-12-20 1998-03-09 山之内製薬株式会社 ＧＰ▲ＩＩ▼ｂ／▲ＩＩＩ▼ａと反応性のヒト型化抗体

Also Published As

Publication number Publication date
NZ502819A (en) 2002-09-27
ES2204937T5 (es) 2009-07-06
DE69433091D1 (de) 2003-10-02
HK1054682A1 (en) 2003-12-12
AU1172495A (en) 1995-05-23
DE69433091T3 (de) 2009-07-30
JPH09504795A (ja) 1997-05-13
CN1140295C (zh) 2004-03-03
UA37249C2 (uk) 2001-05-15
ATE247980T1 (de) 2003-09-15
RU2158135C2 (ru) 2000-10-27
NZ527820A (en) 2005-04-29
EP1334730A2 (de) 2003-08-13
ES2204937T3 (es) 2004-05-01
CA2175214A1 (en) 1995-05-11
CN1142189A (zh) 1997-02-05
CN1404877A (zh) 2003-03-26
EP0725655B2 (de) 2009-04-15
EP0725655A1 (de) 1996-08-14
EP0725655B1 (de) 2003-08-27
DK0725655T3 (da) 2004-01-05
AU8959398A (en) 1999-01-14
HK1054682B (zh) 2006-05-04
PT725655E (pt) 2004-01-30
EP1334730A3 (de) 2003-12-03
DE69433091T2 (de) 2004-06-03
WO1995012412A1 (en) 1995-05-11
CN1230201C (zh) 2005-12-07

Similar Documents

Publication Publication Date Title
DE68929380D1 (de) Plättchen-spezifisches chimärisches immunglobulin
AU1611192A (en) Fibrinogen receptor antagonists
EP0528931A4 (en) Humanized chimeric anti-icam-1 antibodies, methods of preparation and use
SG52709A1 (en) Substituted imidazoles
DK0673255T3 (da) Monoklonale antistoffer, som specifikt binder til vaskulært tumorendotel, og anvendelser deraf
ATE268818T1 (de) Ctla4-mutantmoleküle und deren verwendung
EP0478362A3 (en) Fibrinogen receptor antagonists
EE04752B1 (et) Monoklonaalne antikeha, seda tootev hübridoom ja antikeha kasutamine
GR3024465T3 (en) Substituted mono- and bipyridylmethylpyridone as angiotensine II antagonists.
DK0725655T3 (da) Anvendelse af forbindelser, der er i stand til at binde til glycoproteinet gpllb/llla, til forebyggelse af stenose og restenose
ZA92467B (en) Mixed specificity fusion proteins
ATE296312T1 (de) Metalkomplexbildner
FI962505A0 (fi) Stabiloitu vinyylikloridiseos
DE69127334D1 (de) Verabreichung von Mitteln
DE69413090D1 (de) Verwendung von 5-Amino-Phthaloylhydrazid als antihypoxisches und defensives Mittel
ITTO911031A0 (it) Procedimento per la compensazione dell'errore di angolo di sterzatura in uno sterzo totalmente idraulico, e sterzo totalmente idraulico.
ATE177166T1 (de) Zweibandagige bodenverdichtungsvorrichtung und deren lenkung
FI961339A0 (fi) Triaryylieteenijohdannaiset käytettäväksi hoidossa
GB9100741D0 (en) Treatment of disease
Farrugia Purity Of Factor Vlll Concentrates And Immune Function In Hemophiliacs
Lord et al. Three Graphical Preprocessors Try to Fulfill the Promise of CADD as Design Tool
Aloman Calculus for the liquidus curve from the binary equilibrium diagram with a compound A sub m B sub n that completes dissociates at melting
ES1019674U (es) Bolsa higienica para animales domesticos.
HUT64038A (en) Process for producing angiotensin ii receptor blocking imidazole derivatives, as well as pharmaceutical compositions comprising such derivatives in themeselves and combined with diuretics and non-steroidal antiinflammatory agents